Skip to content

Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients

Investigation of Fall Risk Factors and Implementation of an Exercise Intervention for Prevention of Falls in Patients With Multiple Myeloma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07044427
Acronym
Myfall
Enrollment
60
Registered
2025-07-01
Start date
2024-02-02
Completion date
2026-12-30
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance Training Effects, Fall Risk Factors, Multiple Myeloma, Strength Training Effects

Keywords

Multiple Myeloma, Fall risk, pertubation training, strength training, Balance

Brief summary

Approximately one third of the population over the age of 65 falls at least once a year. The risk of falling is in increased in older patients with tumor diseases. In addition to high treatment and care costs for the healthcare system, falls often lead to a decrease of quality of life, a reduction in physical performance and a loss of independence. Despite the high risk, falls in cancer patients have not yet been scientifically investigated in detail. For patients with multiple myeloma in particular, very little data is available on the prevalence, risk factors and effects of falls. In this study, a fall risk assessment is carried out in patients with multiple myeloma. Furthermore, a patient-specific training intervention for fall prevention will be implemented. The aim of the study is to identify possible fall risk factors in multiple myeloma patients and to establish a structured exercise intervention that minimizes the risk of falls and injuries.

Interventions

OTHERStrength and balance training in combination with a treadmill-based pertubation intervention

Patients receive a personalized home-based training plan with strength and balance exercises to be carried out three times a week for six months. In addition, treadmill-based pertubation training is carried out at 2 timepoints.

Sponsors

University Hospital Heidelberg
Lead SponsorOTHER
Bethanien Krankenhaus gGmbH
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with multiple myeloma requiring therapy (at least 6 months of systemic therapy) * ECOG status ≤ 3 * Age ≥18 years * Patients who state that they want to carry out the training program at least 3 times/week and participate in the planned follow-up visits * Ability to give informed consent * Written consent to participate in the study * Sufficient written and spoken German to complete the questionnaire

Exclusion criteria

* Any physical or mental limitations that would prevent participation in the training program or the planned follow-up checks.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of at least 48 out of 72 training sessions with the focus on fall prevention within 24 weeksFrom enrollement to the end of the training intervention at 6 monthsPatients will document the number of training sessions via an online training-app (Physiotec, Bad Wünnenberg, Germany). Feasibility is achieved if 48 of 72 possible training sessions were successfully completed.
Effectivity (fear of falling)Evaluated at the beginning of the study and at the end of the study after 6 monthsFear of falling will be evaluated by a validated questionnaire (FES-I, Falls Efficacy Scale-Inernational). The questionnaire contains 16 items scored on a four-point scale (1=not at all concerned to 4=very concerned). Scores \>23 indicate high concern about falling.

Countries

Germany

Contacts

CONTACTUlrike Dapunt, prof. Dr. med
ulrike.dapunt@med.uni-heidelberg.de+49 622156 32765
STUDY_CHAIRDapunt

University Hospital Heidelberg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026